Adrenal gland- Upk1a negative adrenocortical adenoma
Breast- Upk1a negative invasive breast cancer of no special type (NST)
Colon- Upk1a negative colorectal adenocarcinoma
Esophagus- Upk1a negative squamous cell carcinoma
Kidney- Upk1a negative clear cell renal cell carcinoma
Kidney, pelvis- Invasive urothelial carcinoma with strong, predominantly membranous Upk1a immunostaining of tumor cells
Larynx- Squamous cell carcinoma with moderate Upk1a positivity of about 30_ of cancer cells
Larynx- Upk1a negative squamous cell carcinoma
Liver- Upk1a negative hepatocellularcellular carcinoma
Lung- Upk1a negative adenocarcinoma
Lung- Upk1a negative malignant mesothelioma (epitheloid)
Lymph node- Upk1a negative Hodgkin’s lymphoma
Oral cavity- Upk1a negative squamous cell carcinoma
Ovary- Brenner tumor with strong Upk1a immunostaining of a small fraction of tumor cells
Ovary- Upk1a negative serous high-grade carcinoma
Pancreas- Upk1a negative ductal adenocarcinoma
Pancreas- Upk1a negative neuroendocrine tumor
Penis- Upk1a negative squamous cell carcinoma
Prostate- Upk1a negative adenocarcinoma (Gleason 3+3=6)
Salivary gland- Upk1a negative Warthin tumor
Soft tissue- Upk1a negative liposarcoma
Stomach- Upk1a negative gastric adenocarcinoma (diffuse type)
Stomach- Upk1a negative gastric adenocarcinoma
Stomach- Upk1a negative gastrointestinal stromal tumor (GIST)
Testis- Upk1a negative seminoma
Thymus- Upk1a negative thymoma
Thyroid- Follicular cancer with moderate to strong, predominantly cytoplasmic Upk1a staining of tumor cells
Thyroid- Papillary cancer with weak cytoplasmic Upk1a positivity of tumor cells
Urinary bladder- Muscle-invasive urothelial carcinoma with strong Upk1a immunostaining of 90% of tumor cells
Urinary bladder- Muscle-invasive urothelial carcinoma with strong Upk1a immunostaining of tumor cells
Urinary bladder- Non-invasive urothelial carcinoma (low grade, pTaG2) with strong Upk1a immunostaining of tumor cells
Urinary bladder- Upk1a negative muscle-invasive urothelial carcinoma
Urinary bladder- Upk1a negative small cell carcinoma